Financials

  • Market Capitalization 166.98 M
  • Employee 13
  • Founded 2006
  • CEO Nadav Kidron
  • Website www.oramed.com
  • Headquarter Delaware, United States
  • FIGI BBG000LRYR36
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
1.9
Price to sales ratio
60.45
Dividends per share
0.25
Dividend yield %
8.77

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3736
ANTX
AN2 Therapeutics, Inc. - Common Stock
4.73 USD+3.96%+7.74%-0.21%+337.96%170.36 M USD
3744
IPHA
Innate Pharma S.A. - American Depositary Shares
1.80 USD+0.56%-4.76%-0.55%+5.26%168.69 M USD
3750
PEPG
PepGen Inc. - Common Stock
2.41 USD-1.23%+13.68%+61.74%+86.82%166.70 M USD
3761
ALEC
Alector, Inc. - Common Stock
1.48 USD-1.99%-22.92%-5.13%-12.43%164.32 M USD

Frequently asked questions about Oramed Pharmaceuticals Inc. - Common Stock

What is the Oramed Pharmaceuticals Inc. - Common Stock stock price today?

The current price of Oramed Pharmaceuticals Inc. - Common Stock (ORMP) is 4.08. Over the past 24 hours, the stock has changed by +3.03%. Follow the ORMP chart for real-time price dynamics.

What is the stock ticker of Oramed Pharmaceuticals Inc. - Common Stock?

Oramed Pharmaceuticals Inc. - Common Stock trades under the ticker ORMP. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Oramed Pharmaceuticals Inc. - Common Stock stock going up?

ORMP has changed by -7.06% over the last week, +5.15% over the last month, and +92.45% over the last year. Review the chart to see whether the current move is part of a broader trend.

Does Oramed Pharmaceuticals Inc. - Common Stock release financial reports?

Yes. You can track Oramed Pharmaceuticals Inc. - Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.

What was Oramed Pharmaceuticals Inc. - Common Stock net income for the last quarter?

Oramed Pharmaceuticals Inc. - Common Stock reported net income of 38.31 M for the last quarter. The previous quarter showed 10.01 M, which means net income changed by +282.76%.

How many employees does Oramed Pharmaceuticals Inc. - Common Stock have?

As of the latest available data, Oramed Pharmaceuticals Inc. - Common Stock has 13 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Oramed Pharmaceuticals Inc. - Common Stock stock?

You can buy Oramed Pharmaceuticals Inc. - Common Stock (ORMP) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Oramed Pharmaceuticals Inc. - Common Stock stock?

Investing in Oramed Pharmaceuticals Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ORMP chart and related analysis on metatrader.com as part of your research.

Oramed Pharmaceuticals Inc. - Common Stock

Oramed Pharmaceuticals Inc., is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange.

News